Home › Products › Oncology › Brukinsa 80mg Capsule
Brukinsa 80mg Capsule
Salt Composition: ZANUBRUTINIB
- Manufacturer: GLENMARK PHARMACEUTICALS LTD
- Pack Size: 120 CAPSULE(s) IN A BOTTLE
- Dosage Form: CAPSULE
- Strength: 80MG
- Prescription Required
- Storage: Store the medicine at room temperature (20 - 25°C), away from moisture and heat. Keep the medicine out of reach of children and pets. Do not share your medication with others, even if they have similar symptoms.
₹224500.00₹279375.00
Inclusive of all taxes
Product Introduction
Brukinsa 80mg Capsule is a prescription medicine used to treat certain types of blood cancers. It contains Zanubrutinib, which belongs to a class of drugs called BTK inhibitors. These medicines work by blocking a protein that helps cancer cells grow and survive, thereby slowing down or stopping the spread of cancer in the body. Doctors typically prescribe Brukinsa 80mg Capsule to patients who have already received other treatments for blood cancer. It is taken orally and usually supplied as a capsule. While it can be effective, it is not suitable for all patients. Patients with serious liver problems, certain heart conditions, or women who are pregnant or breastfeeding should not use this medicine unless a doctor determines it is safe. Before starting treatment, your doctor will conduct blood tests to ensure the medicine is appropriate for you. Your doctor will also monitor your health regularly during treatment to confirm that your condition remains stable.
Uses
Brukinsa 80mg Capsule is FDA-approved for the treatment of: Mantle Cell Lymphoma (MCL) – in adults who’ve had at least one previous treatment Chronic Lymphocytic Leukaemia (CLL) or Small Lymphocytic Lymphoma (SLL) Waldenström’s Macroglobulinemia (WM) Marginal Zone Lymphoma (MZL) – after treatment with an anti-CD20 medicine Follicular Lymphoma (FL) – limited use or under review in some places
How it works
Zanubrutinib targets a protein in the body called BTK, which helps cancer cells survive and grow. By blocking this protein, the medicine weakens the cancer cells, making it harder for them to multiply. Over time, this can help shrink the cancer or stop it from spreading. It doesn’t cure cancer, but it helps manage it and may improve how you feel and function during treatment.
Side Effects
Common Side Effects: Diarrhea Muscle pain Cough Rash Low white blood cell count Tiredness Bruising easily Serious Side Effects: Serious infections (fever, chills, shortness of breath) Bleeding or blood in stool/urine Irregular heartbeat or chest pain Liver problems (yellowing of skin or eyes) Severe allergic reactions (swelling, rash, difficulty breathing)
Expert Tips
Take it at the same time daily – This helps maintain a steady level of the medicine in your body for better effectiveness. Avoid grapefruit and grapefruit juice – They can interfere with how the medicine works and may increase side effects. Watch for signs of infection – Fever, chills, or cough should be reported to your doctor immediately, as the medicine can weaken your immune system. Don’t skip medical checkups – Regular blood tests are important to monitor blood counts, liver function, and how well the treatment is working. Tell your doctor about all medicines you're taking – Especially blood thinners, antibiotics, and antifungals, as they may interact with Brukinsa 80mg Capsule.
References
- https://d1e94vsyskgtht.cloudfront.net/brukinsa/pdfs/brukinsa-patient-information.pdf
- https://www.brukinsa.com/
- https://www.drugs.com/zanubrutinib.html
- https://www.cancerresearchuk.org/about-cancer/treatment/drugs/zanubrutinib
Safety Advice
Pregnancy: Unsafe Brukinsa 80mg Capsule may cause harm to the unborn baby and is not recommended during pregnancy. Women of childbearing age should use effective birth control during treatment and for at least one week after stopping the medicine.
Lungs: Consult Your Doctor Brukinsa 80mg Capsule may increase the risk of infections, including lung infections. Inform your doctor immediately if you develop cough, fever, or shortness of breath.
Breastfeeding: Unsafe It is unknown whether Brukinsa 80mg Capsule passes into breast milk. However, due to the potential risk to the infant, breastfeeding should be avoided during and for at least one week after the last dose.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.